These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17669846)

  • 1. Can erythropoietin improve skeletal myoblast engraftment in infarcted myocardium?
    Chanséaume S; Azarnoush K; Maurel A; Bellamy V; Peyrard S; Bruneval P; Hagège AA; Menasché P
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):293-7. PubMed ID: 17669846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1alpha.
    Azarnoush K; Maurel A; Sebbah L; Carrion C; Bissery A; Mandet C; Pouly J; Bruneval P; Hagège AA; Menasché P
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):173-9. PubMed ID: 15999059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICVTS on-line discussion A. Equivocal results for cytokine therapy.
    Kan CD; Lee HL
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):297. PubMed ID: 17669847
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of transplanted myoblasts transfected with human growth hormone gene on improvement of ventricular function of rats.
    Rong SL; Lu YX; Liao YH; Wang XL; Wang YJ; Chang C; Wang YQ; Liu QY; Gao YZ; Mi SH
    Chin Med J (Engl); 2008 Feb; 121(4):347-54. PubMed ID: 18304469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICVTS on-line discussion B. Don't give up, yet!
    Stamm C
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):297. PubMed ID: 17669848
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison.
    Hamdi H; Furuta A; Bellamy V; Bel A; Puymirat E; Peyrard S; Agbulut O; Menasché P
    Ann Thorac Surg; 2009 Apr; 87(4):1196-203. PubMed ID: 19324150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy.
    Memon IA; Sawa Y; Miyagawa S; Taketani S; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):646-53. PubMed ID: 16153908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts.
    Kutschka I; Kofidis T; Chen IY; von Degenfeld G; Zwierzchoniewska M; Hoyt G; Arai T; Lebl DR; Hendry SL; Sheikh AY; Cooke DT; Connolly A; Blau HM; Gambhir SS; Robbins RC
    Circulation; 2006 Jul; 114(1 Suppl):I174-80. PubMed ID: 16820569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myoblast-based cardiac repair: xenomyoblast versus allomyoblast transplantation.
    Guo C; Haider HKh; Shim WS; Tan RS; Ye L; Jiang S; Law PK; Wong P; Sim EK
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1332-9. PubMed ID: 17976470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing transplanted cell survival with cell-based angiogenic gene therapy.
    Yau TM; Kim C; Ng D; Li G; Zhang Y; Weisel RD; Li RK
    Ann Thorac Surg; 2005 Nov; 80(5):1779-86. PubMed ID: 16242455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining erythropoietin infusion with intramyocardial delivery of bone marrow cells is more effective for cardiac repair.
    Zhang D; Zhang F; Zhang Y; Gao X; Li C; Yang N; Cao K
    Transpl Int; 2007 Feb; 20(2):174-83. PubMed ID: 17239026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.
    Dib N; Michler RE; Pagani FD; Wright S; Kereiakes DJ; Lengerich R; Binkley P; Buchele D; Anand I; Swingen C; Di Carli MF; Thomas JD; Jaber WA; Opie SR; Campbell A; McCarthy P; Yeager M; Dilsizian V; Griffith BP; Korn R; Kreuger SK; Ghazoul M; MacLellan WR; Fonarow G; Eisen HJ; Dinsmore J; Diethrich E
    Circulation; 2005 Sep; 112(12):1748-55. PubMed ID: 16172284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engraftment is optimal when myoblasts are transplanted early: the role of hepatocyte growth factor.
    O'Blenes SB; Li AW; Chen R; Arora RC; Horackova M
    Ann Thorac Surg; 2010 Mar; 89(3):829-35. PubMed ID: 20172138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesothelial cells vs. skeletal myoblasts for myocardial infarction.
    Bourahla B; Shafy A; Meilhac O; Elmadbouh I; Michel JB; Chachques JC
    Asian Cardiovasc Thorac Ann; 2010 Feb; 18(2):153-60. PubMed ID: 20304850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.
    Menasché P; Alfieri O; Janssens S; McKenna W; Reichenspurner H; Trinquart L; Vilquin JT; Marolleau JP; Seymour B; Larghero J; Lake S; Chatellier G; Solomon S; Desnos M; Hagège AA
    Circulation; 2008 Mar; 117(9):1189-200. PubMed ID: 18285565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramyocardial microdepot injection increases the efficacy of skeletal myoblast transplantation.
    Ott HC; Kroess R; Bonaros N; Marksteiner R; Margreiter E; Schachner T; Laufer G; Hering S
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1017-21. PubMed ID: 15896611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 expression enhances myoblast sheet transplantation therapy for acute myocardial infarction.
    Kitabayashi K; Siltanen A; Pätilä T; Mahar MA; Tikkanen I; Koponen J; Ono M; Sawa Y; Kankuri E; Harjula A
    Cell Transplant; 2010; 19(5):573-88. PubMed ID: 20089207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart.
    Niagara MI; Haider HKh; Jiang S; Ashraf M
    Circ Res; 2007 Mar; 100(4):545-55. PubMed ID: 17234963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 enhances the efficacy of myoblast transplantation with its multiple functions in the chronic myocardial infarction rat model.
    Kanemitsu N; Tambara K; Premaratne GU; Kimura Y; Tomita S; Kawamura T; Hasegawa K; Tabata Y; Komeda M
    J Heart Lung Transplant; 2006 Oct; 25(10):1253-62. PubMed ID: 17045939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function.
    Scorsin M; Hagège A; Vilquin JT; Fiszman M; Marotte F; Samuel JL; Rappaport L; Schwartz K; Menasché P
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1169-75. PubMed ID: 10838534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.